NCT05658588

Brief Summary

Impact of the hemoadsorption with Cytosorb on hemodynamic in pediatric patients with septic shock: a prospectic pediatric pilot study

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2019

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2021

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

December 4, 2022

Completed
17 days until next milestone

First Posted

Study publicly available on registry

December 21, 2022

Completed
Last Updated

December 21, 2022

Status Verified

December 1, 2022

Enrollment Period

2.1 years

First QC Date

December 4, 2022

Last Update Submit

December 13, 2022

Conditions

Keywords

Pediatric Septic ShockBlood PurificationAKIPediatric Critical CareHemoperfusionCKRT

Outcome Measures

Primary Outcomes (1)

  • Vasopressors and inotropes reduction

    Proportion of patients who achieved a significant reduction in vasopressors or inotropes dose from baseline to the end of treatment.

    96 hours

Secondary Outcomes (1)

  • Changes in hemodynamic parameters

    96 hours

Other Outcomes (4)

  • Organ dysfunction change

    96 hours

  • Biomarkers of infection change

    96 hours

  • Perfusion indexes change

    96 hours

  • +1 more other outcomes

Study Arms (1)

Hemoperfusion and CKRT in pediatric septic shock

EXPERIMENTAL

Hemoperfusion with Cytosorb in combination with CKRT

Device: Cytosorb

Interventions

CytosorbDEVICE

Cytosorb cartridge It is composed of polystyrene divinylbenzene and polyvinylpyrrolidone copolymers and targets molecules in the 5-50 kDa range, which includes the molecular mass of several cytokines

Also known as: CKRT
Hemoperfusion and CKRT in pediatric septic shock

Eligibility Criteria

Age1 Year - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children weighing ≥ 10 kg
  • Septic shock as defined by the International Pediatric Consensus Conference
  • Need for Continuous Renal Replacement Therapy (CRRT) = acute kidney injury defined by the KDIGO criteria (16) AND/OR fluid overload ≥ 10%

You may not qualify if:

  • Refused consensus by parents
  • Concomitant use of other extracorporeal blood purification techniques.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gabriella Bottari

Rome, 00151, Italy

Location

Related Publications (1)

  • Bottari G, Guzzo I, Cappoli A, Labbadia R, Perdichizzi S, Serpe C, Creteur J, Cecchetti C, Taccone FS. Impact of CytoSorb and CKRT on hemodynamics in pediatric patients with septic shock: the PedCyto study. Front Pediatr. 2023 Sep 15;11:1259384. doi: 10.3389/fped.2023.1259384. eCollection 2023.

MeSH Terms

Conditions

Shock, Septic

Condition Hierarchy (Ancestors)

SepsisInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShock

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: a two-stage plan by Simon
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor, Principal Investigator, Pediatric Intensivist

Study Record Dates

First Submitted

December 4, 2022

First Posted

December 21, 2022

Study Start

September 1, 2019

Primary Completion

October 1, 2021

Study Completion

October 1, 2021

Last Updated

December 21, 2022

Record last verified: 2022-12

Locations